Back

Pharmacological Management of HCM

19 March 2026 (09:00 - 09:30)
Organised by: Logo
Seminar Presentation Part of: Level I - Session 2 : Management of HCM Physical Inactivity and Exercise Open Access EAPC Course : Hypertrophic Cardiomyopathy 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Professor Iacopo Olivotto

University of Florence, Florence (Italy)

4 More presentations in this session

Presentation thumbnail
Lifestyle, Exercise & HCM: What’s Safe?
Professor S. Sharma (London, GB)
Slides Video
Presentation thumbnail
When to Refer for Septal Reduction Therapy
Professor M. Tome Esteban (London, GB)
Slides
Presentation thumbnail
Interactive Case Workshop II: Risk Stratification
Professor M. Tome Esteban (London, GB)
Slides Video
Presentation thumbnail
Wrap-Up & Transition to Advanced Course
Doctor G. Finocchiaro (London, GB) Professor M. Pieroni (Florence, IT)
Slides Video

Access the full session

Session thumbnail
Level I - Session 2 : Management of HCM

The Event

Event poster

EAPC Course : Hypertrophic Cardiomyopathy 2026

19 March 2026 09:00 CET
You may be interested in
thumbnail
Congress Session
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
17 May 2025
thumbnail
Congress Presentation
Clinical effects of metoprolol in obstructive hypertrophic cardiomyopathy (TEMPO). A randomized, double-blinded, placebo-controlled crossover trial
27 August 2021
thumbnail
Congress Presentation
Effects of candesartan on left ventricular hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy
28 August 2020
thumbnail
Congress Presentation
Assessing the alignment of obstructive hypertrophic cardiomyopathy pharmacological treatments with ESC guidelines in Germany
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources